• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

    5/8/25 8:35:00 AM ET
    $BLTE
    $COE
    $HCM
    $IH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Real Estate
    Get the next $BLTE alert in real time by email

    NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States.

    Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies.

    There is no fee for participants to log in, attend live presentations and/or ask questions.

    Pre-registration is suggested. Please register here: www.adr.db.com/dbvic

    Conference Agenda May 15th, 2025 (US Eastern Standard Time):

    • 8:00 AM: Bavarian Nordic A/S ((Nasdaq Copenhagen: BAVA, OTC:BVNRY)  
    • 8:30 AM: Viomi Technology Co., Ltd (NASDAQ:VIOT)
    • 9:00 AM: Infineon Technologies AG ((Xetra: IFX, OTC:IFNNY)
    • 9:30 AM: Clicks Group Ltd ((JSE: CLS, OTC:CLCGY)
    • 10:00 AM: First Pacific Company Ltd ((HKEX: 142, OTC:FPAFY)
    • 10:30 AM: HUTCHMED (China) Limited (AIM: HCM, NASDAQ:HCM, and HKEX:13)
    • 11:00 AM: 51Talk Online Education Group (NYSE:COE)
    • 11:30 AM: Yiren Digital Ltd. (NYSE:YRD)
    • 12:00 PM: ABB Ltd. ((SIX: ABBN, OTC:ABBNY)
    • 12:30 PM: Belite Bio, Inc  (NASDAQ:BLTE)
    • 13:00 PM: Epiroc AB ((Nasdaq Stockholm: EPIA, OTC:EPOAY)
    • 13:30 PM: International Airlines Group ((LSE: IAG, MAD: IAG, OTC:ICAGY)
    • 14:00 PM: BDO Unibank, Inc ((PSE: BDO, OTC:BDOUY)
    • 14:30 PM: iHuman Inc. (NYSE:IH)

    The presentations will be available for replay after the conference.

    In addition to specializing in administering cross-border equity structures such as American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. The Bank offers a broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.

    For further information, please contact:

    Dylan Riddle

    Deutsche Bank AG

    Press & Media Relations

    Tel. +12122504982

    Cell. +1(904)3866481

    Email [email protected]

    Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany's leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.

    Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes. Deutsche Bank does not prepare, review, approve or edit any presentations, statements, documents or other information or materials, whether in written, electronic or verbal form, provided by any company participating in such conference, and disclaims any responsibility for the accuracy or adequacy of any such information or materials. Deutsche Bank is not promoting, endorsing or recommending any company participating in the conference.

    The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the "Act") on Form F-6. The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant as to or guarantee the accuracy or completeness of the details contained herein and does not undertake an obligation to update or amend this information. Deutsche Bank, its subsidiaries and/or affiliates disclaims any and all liability to fullest extent permitted by law, whether arising in tort, contract or otherwise, which any of them might otherwise have in respect of the above information. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities in the United States, nor does it constitute an offer or solicitation to any person in any other jurisdiction. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© May 2025 Deutsche Bank AG. All rights reserved.



    Primary Logo

    Get the next $BLTE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLTE
    $COE
    $HCM
    $IH

    CompanyDatePrice TargetRatingAnalyst
    Belite Bio Inc
    $BLTE
    12/14/2023$60.00Buy
    Maxim Group
    HUTCHMED (China) Limited
    $HCM
    11/24/2023Hold → Buy
    Deutsche Bank
    Belite Bio Inc
    $BLTE
    7/28/2023$43.00Overweight
    Cantor Fitzgerald
    Belite Bio Inc
    $BLTE
    7/26/2023$25.00Outperform
    SVB Securities
    iHuman Inc.
    $IH
    12/30/2022$3.10Buy
    Citigroup
    Belite Bio Inc
    $BLTE
    8/1/2022$58.00Buy
    H.C. Wainwright
    HUTCHMED (China) Limited
    $HCM
    5/4/2022Buy → Hold
    Deutsche Bank
    Viomi Technology Co. Ltd
    $VIOT
    12/6/2021$12.50 → $9.50Buy
    Needham
    More analyst ratings

    $BLTE
    $COE
    $HCM
    $IH
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by 51Talk Online Education Group

      SCHEDULE 13D/A - 51Talk Online Education Group (0001659494) (Subject)

      5/7/25 4:32:54 PM ET
      $COE
      Other Consumer Services
      Real Estate
    • SEC Form NT 20-F filed by Viomi Technology Co. Ltd

      NT 20-F - Viomi Technology Co., Ltd (0001742770) (Filer)

      5/1/25 6:16:07 AM ET
      $VIOT
      Consumer Electronics/Appliances
      Consumer Discretionary
    • SEC Form 20-F filed by iHuman Inc.

      20-F - iHuman Inc. (0001814423) (Filer)

      4/28/25 4:01:23 PM ET
      $IH
      Other Consumer Services
      Real Estate

    $BLTE
    $COE
    $HCM
    $IH
    Financials

    Live finance-specific insights

    See more
    • Viomi Technology Co., Ltd Reports Second Half and Full Year 2024 Unaudited Financial Results

      GUANGZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced its unaudited financial results for the second half and full year ended December 31, 2024. Second Half 2024 Financial Highlights1 Net revenues2 reached RMB1,282.4 million (US$175.7 million), an increase of 42.8% from RMB897.9 million for the same period of 2023.Net income was RMB56.8 million (US$7.8 million), compared to a net loss of RMB32.0 million for the same period of 2023. Full Year 2024 Financial Highlights Net revenues were RMB2,119.0 million (US$290.3 million), an increase of 29

      3/25/25 7:00:30 AM ET
      $VIOT
      Consumer Electronics/Appliances
      Consumer Discretionary
    • iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

      BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenues were RMB232.7 million (US$31.9 million), compared with RMB250.4 million in the same period last year.Gross profit was RMB156.4 million (US$21.4 million), compared with RMB178.2 million in the same period last year.Operating income was RMB14.9 million (US$2.0 m

      3/25/25 4:03:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • 51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2024

      SINGAPORE, March 21, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the fourth quarter and full year ended December 31, 2024. Full Year 2024 Financial and Operating Highlights Gross billings[1] for 2024 were US$69.6 million, a 74.4% growth from 2023.Net revenues were US$50.7 million for 2024, an 87.0% increase from US$27.1 million for 2023.The number of active students with attended lesson consumption was approximately 95,000 in 2024, representing an 87.0% increase from approximately 50,800 in 2023.Fourth Quarter 2024 Financia

      3/21/25 6:10:00 AM ET
      $COE
      Other Consumer Services
      Real Estate

    $BLTE
    $COE
    $HCM
    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Maxim Group initiated coverage on Belite Bio with a new price target

      Maxim Group initiated coverage of Belite Bio with a rating of Buy and set a new price target of $60.00

      12/14/23 8:06:18 AM ET
      $BLTE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HUTCHMED upgraded by Deutsche Bank

      Deutsche Bank upgraded HUTCHMED from Hold to Buy

      11/24/23 7:13:23 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Cantor Fitzgerald initiated coverage on Belite Bio with a new price target

      Cantor Fitzgerald initiated coverage of Belite Bio with a rating of Overweight and set a new price target of $43.00

      7/28/23 7:14:28 AM ET
      $BLTE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

      SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

      12/17/24 4:07:04 PM ET
      $COE
      Other Consumer Services
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

      SC 13G/A - Viomi Technology Co., Ltd (0001742770) (Subject)

      11/12/24 6:35:53 AM ET
      $VIOT
      Consumer Electronics/Appliances
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

      SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

      10/10/24 6:45:35 AM ET
      $COE
      Other Consumer Services
      Real Estate

    $BLTE
    $COE
    $HCM
    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UPDATE - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 10:44:07 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 8:35:00 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results

      SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Wednesday, May 14, 2025, at 4:30 p.m. Eastern Time to discuss the Company's financial results and provide a business update for the first quarter ended March 31, 2025. Webcast InformationDate: Wednesday, May 14, 2025Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Webcast Link: https://events.q4inc.com/attendee/137642555 Webcast Link InstructionsYou can join the live webcast by vi

      5/7/25 8:00:00 AM ET
      $BLTE
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $BLTE
    $COE
    $HCM
    $IH
    Leadership Updates

    Live Leadership Updates

    See more
    • HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

      HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:​HCM, HKEX:​13) today announces that Mr Wong Tak Wai (Mr Alvin Wong) is appointed as an Independent Non-executive Director and a member of the Audit Committee of the Company with effect from March 6, 2025. Mr Wong has over 35 years of extensive experience in accounting, auditing and corporate finance. He has acted in a pivotal role in assisting companies with their stock exchange listings and has been instrumental in completing numerous mergers and acquisitions. After a distinguished career spanning more than three decades, Mr Wong retired as

      3/5/25 5:00:00 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Viomi Technology Co., Ltd Appoints New President of Operations to Promote High-quality Business Development

      GUANGZHOU, China, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:VIOT), a leading technology company for home water solutions in China, today announced the appointment of Mr. Guang Wu as President of Operations, effective December 4, 2024. In this role, Mr. Wu will focus on driving high-quality business development and enhancing operational efficiency. Mr. Wu brings over 20 years of experience in business development and marketing within the domestic home appliances and home furnishing industry. Prior to joining Viomi, he served as Vice President and General Manager of Domestic Marketing at Sleemon Group. Before that, he managed domestic m

      12/4/24 4:00:00 AM ET
      $VIOT
      Consumer Electronics/Appliances
      Consumer Discretionary
    • HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

      HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:HCM, HKEX:13) today announces that Dr Chaohong Hu (Dr Mary Hu) is appointed as an Independent Non-executive Director and a member of the Technical Committee of the Company with effect from November 21, 2024. Dr Hu has over 20 years of experience in the development of therapeutic antibodies, antibody-drug conjugates, and vaccines. Throughout her career, she has demonstrated strong leadership and innovative capabilities, leading various research and development initiatives. Dr Hu's expertise spans from early-stage discovery to clinical developme

      11/20/24 4:30:00 AM ET
      $HCM
      Biotechnology: Pharmaceutical Preparations
      Health Care